Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program

Cited by (1,002)

Items 601–700 of 1,002

  1. Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup
    Jakob Anninga, Piero Picci, Marta F. Fiocco, Herman M. J. A. Kroon, D. Vanel, Marco Alberghini, Hans A. J. Gelderblom, Pancras C.W. Hogendoorn · 2012 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  2. Bone sarcoma incidence in the Netherlands
    Louren M. Goedhart, Vincent K.Y. Ho, P. D. S. Dijkstra, Hendrik W. B. Schreuder, Gerard R. Schaap, Joris J. W. Ploegmakers, Ingrid C.M. van der Geest, Michiel A. J. van de Sande, Jos A. M. Bramer, Albert J.H. Suurmeijer et al. · 2019 · Cancer Epidemiology
  3. Future directions in soft tissue sarcoma treatment
    Francis Hall, Victor Manuel Villalobos, Breelyn Ann Wilky · 2019 · Current Problems in Cancer
  4. New insights into antimetastatic signaling pathways of melatonin in skeletomuscular sarcoma of childhood and adolescence
    Ko‐Hsiu Lu, Chiao‐Wen Lin, Yi‐Hsien Hsieh, Shih‐Chi Su, Russel Joseph Reiter, Shun‐Fa Yang · 2020 · Cancer and Metastasis Reviews
  5. Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma
    Laura Bongiovanni, Francesca Mazzocchetti, Daniela Malatesta, Mariarita Romanucci, Andrea Ciccarelli, Paolo Buracco, Raffaella De Maria, Chiara Palmieri, Marina Martano, Emanuela Maria Morello et al. · 2012 · BMC Veterinary Research
  6. Clinical implication of long noncoding RNA 91H expression profile in osteosarcoma patients
    Wei-Dong Mao, Qingfeng Lin, Dong Shen, Zhili Liu, Jun Su, Wenkai Xia · 2016 · OncoTargets and Therapy
  7. Prognostic factors to survival of patients with chondroblastic osteosarcoma
    Hui-Hui Sun, Xiangyang Chen, Jiaqu Cui, Zhaoming Zhou, Kaijin Guo · 2018 · Medicine
  8. Genetic determinants of childhood and adult height associated with osteosarcoma risk
    Chenan Zhang, Libby M. Morimoto, Adam J. de Smith, Helen M. Hansen, Julio Gonzalez‐Maya, Alyson A. Endicott, Ivan V. Smirnov, Catherine Metayer, Qingyi Wei, William C. Eward et al. · 2018 · Cancer
  9. Hsa-miR-889-3p promotes the proliferation of osteosarcoma through inhibiting myeloid cell nuclear differentiation antigen expression
    Dawei Ge, Hongtao Chen, Shengnai Zheng, Bin Zhang, Yingbin Ge, Lei Yang, Xiaojian Cao · 2019 · Biomedicine & Pharmacotherapy
  10. Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma
    Ran Wei, Pichaya Thanindratarn, Dylan C. Dean, Francis John Hornicek, Wei Guo, Zhenfeng Duan · 2020 · Journal of Orthopaedic Research®
  11. State-of-the-art, approved therapeutics for the pharmacological management of osteosarcoma
    Cristina Meazza, Sebastian Dorin Asaftei · 2021 · Expert Opinion on Pharmacotherapy
  12. Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta‐Analysis
    Xiaotong Song, Hao Zhang, Fanxing Yin, Panpan Guo, Xiaocheng Yang, Jinzhu Liu, Yanshuo Han, Zhaozhou Ren · 2021 · Mediators of Inflammation
  13. Advances in the Treatment of Pediatric Bone Sarcomas
    Patrick Joseph Grohar, Katherine A. Janeway, Luke Devon Maese, Joshua David Schiffman · 2017 · American Society of Clinical Oncology Educational Book
  14. Application of interpretable machine learning algorithms to predict distant metastasis in osteosarcoma
    Bing-Li Bai, Zongyi Wu, Sheji Weng, Qing Yang · 2022 · Cancer Medicine
  15. HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study
    Sarah Gorlick, Donald A. Barkauskas, Mark Krailo, Sajida Piperdi, Rebecca S. Sowers, Jonathan Benjamin Gill, David Geller, Robert Lor Randall, Katherine A. Janeway, Cindy L. Schwartz et al. · 2014 · Pediatric Blood & Cancer
  16. Comparison of non-coding RNAs in human and canine cancer
    Siegfried Wagner, Saskia Willenbrock, Ingo J. A. Nolte, Hugo Murua Escobar · 2013 · Frontiers in Genetics
  17. Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis
    Alison Roos, Laura Satterfield, Shuying Zhao, Daniel G. Fuja, Ryan Lane Shuck, John M. Hicks, Lawrence A. Donehower, Jason Todd Yustein · 2015 · British Journal of Cancer
  18. Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)
    David S. Geller, Jonathan Morris, Ekaterina Revskaya, Mani D. Kahn, Wendong Zhang, Sajida Piperdi, Amy Park, Pratistha Koirala, Hillary M. Guzik, Charles B. Hall et al. · 2016 · Nuclear Medicine and Biology
  19. Serine/Threonine Kinase 35, a Target Gene of STAT3, Regulates the Proliferation and Apoptosis of Osteosarcoma Cells
    Zhong Wu, Jie Liu, Siyuan Hu, Yuchang Zhu, Shaohua Li · 2018 · Cellular Physiology and Biochemistry
  20. Mannose Promotes Metabolic Discrimination of Osteosarcoma Cells at Single-Cell Level by Mass Spectrometry
    Zhuyin Fang, Ruihua Wang, Hansen Zhao, Huan Yao, Jin Ouyang, Xinrong Zhang · 2020 · Analytical Chemistry
  21. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
    Weiping Ji, Nengbin He · 2015 · Europe PMC (PubMed Central)
  22. Advances in Therapy for Pediatric Sarcomas
    Aaron R. Weiss, Jonathan Benjamin Gill, John Goldberg, Joanne Lagmay, Holly L. Spraker‐Perlman, Rajkumar Venkatramani, Damon R. Reed · 2014 · Current Oncology Reports
  23. MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a
    Hui Zhou, Minglei Zhang, Hongping Yuan, Wei Zheng, Chunyan Meng, DONGXU ZHAO · 2015 · Oncology Reports · Retracted
  24. MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS
    Zili Wang, Rongzhen He, Hansong Xia, YU WEI, Song Wu · 2016 · Experimental and Therapeutic Medicine · Retracted
  25. A facile microwave synthetic route for ferrite nanoparticles with direct impact in magnetic particle hyperthermia
    Antonios Makridis, I. Chatzitheodorou, Konstantina Topouridou, Maria P. Yavropoulou, Mavroeidis Angelakeris, C. Dendrinou-Samara · 2016 · Materials Science and Engineering C
  26. Prognostic factors for survival among patients with primary bone sarcomas of small bones
    Zhan Wang, Shu Li, Yong Li, Nong Lin, Xin Huang, Meng Liu, Weibo Pan, Xiaobo Yan, Lingling Sun, Hengyuan Li et al. · 2018 · Cancer Management and Research
  27. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo
    Min Mao, Tao Zhang, Zhuoying Wang, Hongsheng Wang, Jing Xu, Fei Yin, Gangyang Wang, Mengxiong Sun, Zongyi Wang, Yingqi Hua et al. · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  28. DDX11-AS1 contributes to osteosarcoma progression via stabilizing DDX11
    Hui Zhang, Jiangtao Lin, Junjun Chen, Wenqi Gu, Yanjie Mao, Haixia Wang, Yahui Zhang, Wanjun Liu · 2020 · Life Sciences
  29. Preclinical Testing of a Novel Niclosamide Stearate Prodrug Therapeutic (NSPT) Shows Efficacy Against Osteosarcoma
    Gireesh B. Reddy, David L. Kerr, Ivan Spasojević, Artak G. Tovmasyan, David S. Hsu, Brian E. Brigman, Jason A. Somarelli, David Needham, William C. Eward · 2020 · Molecular Cancer Therapeutics
  30. Circ-XPR1 promotes osteosarcoma proliferation through regulating the miR-214-5p/DDX5 axis
    Xiaohuan Mao, Shuren Guo, Lan Gao, Gang� Li · 2020 · Human Cell
  31. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma
    Haoli Jiang, Wei Guo, Shanyou Yuan, Lixia Song · 2020 · BioMed Research International
  32. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis
    Chao Zhang, Lin Wang, Chuang Xiong, Runhan Zhao, Hao Liang, Xiaoji Luo · 2021 · Journal of Orthopaedic Surgery and Research
  33. Multifunctional 3D-printed bioceramic scaffolds: Recent strategies for osteosarcoma treatment
    Xingran Liu, Yihao Liu, Lei Qiang, Ren Ya, Yixuan Lin, Han Li, Qiuhan Chen, Shuxin Gao, Xue Yang, Changru Zhang et al. · 2023 · Journal of Tissue Engineering
  34. Hydroxyapatite coated titanium with curcumin and epigallocatechin gallate for orthopedic and dental applications
    Priya Kushram, Ujjayan Majumdar, Susmita Bose · 2023 · Biomaterials Advances
  35. Daphnoretin Induces Cell Cycle Arrest and Apoptosis in Human Osteosarcoma (HOS) Cells
    Shoubin Gu, Jinhai He · 2012 · Molecules
  36. ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas
    M. Wilhelm, Uta Dirksen, Stefan Bielack, Jeremy Simon Whelan, Ian J. Lewis, Heribert Jürgens, Stefano Maria Ferrari, Kirsten Sundby Hall, A.M. Cleton-Jansen, Dan Stark · 2014 · Annals of Oncology
  37. Second primary osteosarcomas in patients with retinoblastoma
    Tomohiro Fujiwara, Miyuki Fujiwara, Kunihiko Numoto, Koichi Ogura, Akihiko Yoshida, Tsukasa Yonemoto, Shigenobu Suzuki, Akira Kawai · 2015 · Japanese Journal of Clinical Oncology
  38. Tissue engineering and regenerative medicine in musculoskeletal oncology
    Boris Michael Holzapfel, Ferdinand Wagner, Laure C. Martine, Stephan Reppenhagen, Maximilian Rudert, Michael Schuetz, James William Denham, Jan‐Thorsten Schantz, Dietmar Werner Hutmacher · 2016 · Cancer and Metastasis Reviews
  39. Ferulic acid promoting apoptosis in human osteosarcoma cell lines
    Xu-dong Zhang, Qiang Wu, Shuhua Yang · 2017 · Pakistan Journal of Medical Sciences
  40. Immunohistochemical Validation of Spontaneously Arising Canine Osteosarcoma as a Model for Human Osteosarcoma
    Awf A. Al-Khan, H.J. Gunn, Michael J. Day, Mourad Tayebi, Stewart D. Ryan, C A Kuntz, Eman Saad, Samantha J. Richardson, Janine A. Danks · 2017 · Journal of Comparative Pathology
  41. MicroRNA-192 inhibits the proliferation, migration and invasion of osteosarcoma cells and promotes apoptosis by targeting matrix metalloproteinase-11
    Guowei Shang, Yang Mi, Yingwu Mei, Guanghui Wang, Yadong Wang, Xinjie Li, Yisheng Wang, Yuebai Li, Guoqiang Zhao · 2018 · Oncology Letters
  42. Preoperative surgical risk stratification in osteosarcoma based on the proximity to the major vessels
    Tomohiro Fujiwara, Manuel Ricardo Medellin Rincon, Andrea Sambri, Yusuke Tsuda, Ján Balko, Vaiyapuri P. Sumathi, Jonathan Gregory, Lee Marcus Jeys, A. Abudu · 2019 · The Bone & Joint Journal
  43. LHX2 promotes malignancy and inhibits autophagy via mTOR in osteosarcoma and is negatively regulated by miR-129-5p
    Honghai Song, Jiaming Liu, Xin Wu, Yang Zhou, Xuanyin Chen, Jiangwei Chen, Keyu Deng, Chunxia Mao, Shan-Hu Huang, Zhili Liu · 2019 · Aging
  44. Crude extract of Rheum palmatum inhibits migration and invasion of U-2 OS human osteosarcoma cells by suppression of matrix metalloproteinase-2 and -9
    Shu‐Chun Hsu, Ju-Hwa Lin, Shu-Wen Weng, Fu‐Shin Chueh, Chien-Chih Yu, Kung-Wen Lu, W. Gibson Wood, Jing‐Gung Chung · 2013 · Biomedicine
  45. Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression
    Xiliang Guan, Yufen Xu, Ju-fen Zheng · 2020 · Oncology Reports
  46. Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and PTEN/PI3K/AKT pathway in osteosarcoma cells
    Jiali Yang, Hui Jiang, Qiqi Fu, Haokuan Qin, Yinghua Li, Muqing Liu · 2023 · Journal of Photochemistry and Photobiology B Biology
  47. Probiotic Biofilm Modified 3D‐Printing Scaffolds for Improving Chemo‐Immunotherapy of Bone Tumor and Promoting Osteogenesis
    Hui-Yun Gu, Jin‐Xuan Fan, Peng Bao, Wen‐Qiang Qu, Zhong‐Bao Hu, Baiwen Qi, Xian‐Zheng Zhang, Aixi Yu · 2023 · Advanced Functional Materials
  48. The microRNA-217 functions as a tumor suppressor and is frequently downregulated in human osteosarcoma
    Baoyong Sun, Mingshan Yang, Min Li, Fangxin Wang · 2015 · Biomedicine & Pharmacotherapy
  49. Inhibition of protein phosphatase 2A with the small molecule LB100 overcomes cell cycle arrest in osteosarcoma after cisplatin treatment
    Chao Zhang, Christopher S. Hong, Xu Hu, Chunzhang Yang, Herui Wang, Dongwang Zhu, Seogin Moon, Pauline Dmitriev, Jie Lu, Jeffrey Y. Chiang et al. · 2015 · Cell Cycle
  50. Promotion of tumour proliferation, migration and invasion bymiR-92bin targeting RECK in osteosarcoma
    Zhenhua Zhou, Zhiwei Wang, Haifeng Wei, Sujia Wu, Xudong Wang, Jianru Xiao · 2016 · Clinical Science
  51. The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo
    William E. Samsa, Murali Krishna Mamidi, Lindsay A. Bashur, R. Scott Elliott, Alexander Miron, Yuqing Chen, Brendan Lee, Edward M. Greenfield, Ricky Chan, David Danielpour et al. · 2020 · Oncogene
  52. Aurora-B knockdown inhibits osteosarcoma metastasis by inducing autophagy via the mTOR/ULK1 pathway
    Xin Wu, Jiaming Liu, Honghai Song, Qikun Yang, Hui Ying, Weilai Tong, Yang Zhou, Zhili Liu · 2020 · Cancer Cell International
  53. Resveratrol is cytotoxic and acts synergistically with NF-κB inhibition in osteosarcoma MG-63 cells
    Ning Xu, Lili Wang, Shiping Fu, Bin Jiang · 2021 · Archives of Medical Science
  54. Osteosarcoma of the Pelvis: Clinical Presentation and Overall Survival
    Jeffrey Brown, David P. Matichak, Kyla D. Rakoczy, John S. Groundland · 2021 · Sarcoma
  55. Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma
    Vafa Meftahpour, Ali Aghebati‐Maleki, Ali Fotouhi, Elham Safarzadeh, Leili Aghebati Maleki · 2021 · EXCLI journal
  56. UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression
    Stephanie Wu, Ahhyun Kim, Yijun Gu, Daniel I. Martinez, Loredana Zocchi, Claire C. Chen, Jocelyne Lopez, Kelsey Salcido, Sarah Singh, Jie Wu et al. · 2022 · Oncogenesis
  57. Progress of phototherapy for osteosarcoma and application prospect of blue light photobiomodulation therapy
    Jiali Yang, Qiqi Fu, Hui Jiang, Yinghua Li, Muqing Liu · 2022 · Frontiers in Oncology
  58. Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study.
    Jessica R.B. Musselman, Tracy L. Bergemann, Julie A. Ross, Charles A. Sklar, Kevin A.T. Silverstein, Erica K. Langer, Sharon A. Savage, Rajaram Nagarajan, Mark Krailo, David M. Malkin et al. · 2012 · PubMed Central
  59. Perinatal factors associated with clinical presentation of osteosarcoma in children and adolescents
    Alyson A. Endicott, Libby M. Morimoto, Cassie Kline, Joseph Leo Wiemels, Catherine Metayer, Kyle M. Walsh · 2016 · Pediatric Blood & Cancer
  60. Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways
    Xiucheng Li, Zhifan Yang, Weiqi Han, Xuanyuan Lu, Songtao Jin, Wanlei Yang, Jianlei Li, Wei He, Yu Qian · 2017 · International Journal of Molecular Medicine
  61. Hyperthermia effect and antibacterial efficacy of Fe3+/Co2+ co‐substitutions in β‐Ca3(PO4)2 for bone cancer and defect therapy
    Ram Kishore Singh, M. Srivastava, Nand Kishore Prasad, Prathapkumar Halady Shetty, S. Kannan · 2017 · Journal of Biomedical Materials Research Part B Applied Biomaterials
  62. Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma
    Kelly M. Makielski, Aaron L. Sarver, Michael S. Henson, Kathleen Stuebner, Antonella Borgatti, Lukkana Suksanpaisan, Caitlin Preusser, Flaviu Tăbăran, Ingrid Cornax, M. Gerard O’Sullivan et al. · 2023 · Molecular Therapy — Oncolytics
  63. TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.
    Gaelle Genevieve Alice Picarda, Valérie Trichet, Stéphane Télétchéa, Dominique Heymann, Françoise Rédiní · 2012 · Europe PMC (PubMed Central)
  64. Transcription factor Snai1-1 induces osteosarcoma invasion and metastasis by inhibiting E-cadherin expression
    Huiguang Yang, YUNQING ZHANG, Zhengming Zhou, Xuefeng Jiang, Aidong Shen · 2014 · Oncology Letters
  65. Genetic Association between ERCC2, NBN, RAD51 Gene Variants and Osteosarcoma Risk: a Systematic Review and Meta-Analysis
    Masoud Mehdinejad, Mohammad Reza Sobhan, Mahta Mazaheri, Masoud Zare-Shehneh, Hossein Neámatzadeh, Seyed Mehdi Kalantar · 2017 · Europe PMC (PubMed Central)
  66. Identification of key gene modules for human osteosarcoma by co-expression analysis
    Jing Zhang, Qing Lan, Jiasheng Lin · 2018 · World Journal of Surgical Oncology
  67. MiR‐125b suppresses the carcinogenesis of osteosarcoma cells via the MAPK‐STAT3 pathway
    Tao Xiao, You Lang Zhou, Hui Li, Liang Xiong, Jing Wang, Zhi‐Hua Wang, Li‐Hong Liu · 2018 · Journal of Cellular Biochemistry
  68. Delay in diagnosis of primary osteosarcoma of bone in children: Have we improved in the last 15 years and what is the impact of delay on diagnosis?
    Shinichirou Yoshida, James Celaire, Chloe Pace, Charles Taylor, Yoichi Kaneuchi, Scott Evans, A. Abudu · 2021 · Journal of bone oncology
  69. Current approaches to management of bone sarcoma in adolescent and young adult patients
    Katrina M. Ingley, Alessandra Maleddu, Franel Le Grange, Craig Gerrand, Archie Bleyer, Ephia Yasmin, Jeremy Simon Whelan, Sandra J. Strauss · 2021 · Pediatric Blood & Cancer
  70. Head and neck osteosarcomas: Analysis of treatment trends and survival outcomes in the United States (2004–2016)
    Timothy Shim, Yeshwant Reddy Chillakuru, Christina C Darwish, Eric J. Chalif, David P. Strum, Daniel A. Benito, Collin F. Mulcahy, Ashkan S. Monfared · 2021 · Head & Neck
  71. Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma
    Adam M. Lee, Asmaa Ferdjallah, Elise Moore, Daniel C. Kim, Aritro Nath, Emily Gustava Greengard, R. Stephanie Huang · 2021 · International Journal of Molecular Sciences
  72. The role of long non-coding RNA FGD5-AS1 in cancer
    Na Shun Meng He, Lin-Biao Xiang, Lei Chen, Hao‐Bin Tong, Keshen Wang, Jie Zhao, Feixue Song, Hanteng Yang, Xinyuan Wei, Zuoyi Jiao · 2022 · Bioengineered
  73. RPN2 Gene Confers Osteosarcoma Cell Malignant Phenotypes and Determines Clinical Prognosis
    Tomohiro Fujiwara, Ryou‐u Takahashi, Nobuyoshi Kosaka, Yutaka Nezu, Akira Kawai, Toshifumi Ozaki, Takahiro Ochiya · 2014 · Molecular Therapy — Nucleic Acids
  74. Emerging concepts for PI3K/mTOR inhibition as a potential treatment for osteosarcoma
    Michael William Bishop, Katherine A. Janeway · 2016 · F1000Research
  75. Lung cells support osteosarcoma cell migration and survival
    Shibing Yu, Mitchell Stephen Fourman, Adel Mahjoub, Jonathan Brendan Mandell, Jared Anthony Crasto, Nicholas Giuseppe Greco, Kurt Richard Weiss · 2017 · BMC Cancer
  76. Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines
    Jian Yang, Weichun Guo, Lu Wang, Ling Yu, Hongjun Mei, Shuo Fang, Anyuan Chen, Yang Liu, Kezhou Xia, Gaiwei Liu · 2017 · Oncology Letters
  77. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK‐3β/β‐catenin signaling
    Gui‐Hong Liang, Ning Liu, Mingtang He, Jie Yang, Zu‐Jian Liang, Xue‐Juan Gao, Ali Hasan Rahhal, Qing‐Yu He, Huan‐Tian Zhang, Zhengang Zha · 2017 · Journal of Cellular Biochemistry
  78. Unusual abdominal metastases in osteosarcoma
    Simon Berhe, Enrico Danzer, Paul A. Meyers, Gerald G Behr, Michael P. LaQuaglia, Anita P. Price · 2017 · Journal of Pediatric Surgery Case Reports
  79. Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway
    Hongzhi Hu, Shangyu Wang, Deyao Shi, Binglong Zhong, Xin Huang, Chunwei Shi, Zengwu Shao · 2019 · OncoTargets and Therapy
  80. Chemotherapeutic Targets in Osteosarcoma: Insights from Synchrotron-MicroFTIR and Quasi-Elastic Neutron Scattering
    Maria Paula M. Marques, Ana L. M. Batista de Carvalho, A. P. Mamede, Inês P. Santos, Victoria García Sakai, Asha Dopplapudi, Gianfelice Cinque, Magda Wolna, Peter Gardner, Luís A. E. Batista de Carvalho · 2019 · The Journal of Physical Chemistry B
  81. The Potential Selective Cytotoxicity of Poly (L- Lactic Acid)-Based Scaffolds Functionalized with Nanohydroxyapatite and Europium (III) Ions toward Osteosarcoma Cells
    Mateusz Sikora, Klaudia A. Marcinkowska, Krzysztof Marycz, Rafal Jakub Wiglusz, Agnieszka Śmieszek · 2019 · Materials
  82. An Innovative Therapeutic Option for the Treatment of Skeletal Sarcomas: Elimination of Osteo- and Ewing’s Sarcoma Cells Using Physical Gas Plasma
    Josephine M. Jacoby, Silas Strakeljahn, Andreas Nitsch, Sander Bekeschus, Peter Hinz, Alexander Mustea, Axel Ekkernkamp, Mladen Vassilev Tzvetkov, Lyubomir Haralambiev, Matthias Bernhard Stope · 2020 · International Journal of Molecular Sciences
  83. Molecular Characterisation of Canine Osteosarcoma in High Risk Breeds
    Siobhan Simpson, Mark Dunning, Simone de Brot, Aziza A. Alibhai, Clara Bailey, Corinne L. Woodcock, Madeline Mestas, Shareen Akhtar, Jennie N. Jeyapalan, Jennifer H. Lothion‐Roy et al. · 2020 · Cancers
  84. COLEC12 regulates apoptosis of osteosarcoma through Toll‐like receptor 4–activated inflammation
    Guang‐Zhang Li, Jian‐Feng Deng, Ying‐Zhao Qi, Ran Liu, Zhi‐Xin Liu · 2020 · Journal of Clinical Laboratory Analysis
  85. Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma.
    Zhang Tie, Rui Bai, Zhongwen Zhai, Gang Zhang, Hong Zhang, Zhenqun Zhao, Deshan Zhou, Wanlin Liu · 2014 · Europe PMC (PubMed Central)
  86. MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma
    Gang Han, Yan Wang, Wenzhi Bi, Jinpeng Jia, Wei Wang · 2014 · Experimental and Therapeutic Medicine
  87. ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma
    Maren Cam, Heather L. Gardner, Ryan David Roberts, Joelle M. Fenger, Denis C. Guttridge D, Cheryl A. London, Hakan Çam · 2016 · Oncotarget
  88. Association between the DNA Repair Gene XRCC3 rs861539 Polymorphism and Risk of Osteosarcoma: a Systematic Review and Meta-Analysis
    Mohammad Reza Sobhan, Mohammad Forat Yazdi, Mahta Mazaheri, Masoud Zare-Shehneh, Hossein Neámatzadeh · 2017 · Europe PMC (PubMed Central)
  89. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma
    Kai Sun, Gong Chen, Hao Peng, Hongsong Fang, Jianlin Zhou, Jianping Li, Sen Chen, Huifeng Zheng · 2017 · Molecular Medicine Reports
  90. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3
    Dong Zhou, Yun Wang · 2019 · Pathology - Research and Practice
  91. MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma Via Dual-Suppressing RhoA/ROCK1 Signaling Pathway
    Jin Long Liu, Jing Li, Jiajia Xu, Fei Xiao, Peng Cui, Zhi Guang Qiao, Xiao Dong Chen, Tao Wei, Xiaoling Zhang · 2018 · Molecular Pharmacology
  92. miR-628-5p promotes growth and migration of osteosarcoma by targeting IFI44L
    Juyong Wang, Ju-Qiang Wang, Shibao Lu · 2019 · Biochemistry and Cell Biology
  93. Oxidized low density lipoprotein receptor 1 promotes lung metastases of osteosarcomas through regulating the epithelial-mesenchymal transition
    Long Jiang, Shanshan Jiang, Wenjie Zhou, Jia Huang, Yongbin Lin, Hao Long, Qingquan Luo · 2019 · Journal of Translational Medicine
  94. Mutation of PFN1 Gene in an Early Onset, Polyostotic Paget-like Disease
    Daniela Merlotti, Maria Materozzi, Simone Bianciardi, Vito Guarnieri, Domenico Rendina, Luca Volterrani, Cristiana Bellan, Christian Mingiano, Tommaso Picchioni, Alessandro Frosali et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
  95. Downregulation of CDC20 suppressed cell proliferation, induced apoptosis, triggered cell cycle arrest in osteosarcoma cells, and enhanced chemosensitivity to cisplatin
    Yi Gao, Caili Guo, Shuqin Fu, Yibing Cheng, Chunlan Song · 2020 · Neoplasma
  96. Tissue Engineering Through 3D Bioprinting to Recreate and Study Bone Disease
    Adriene Pavek, Christopher Nartker, Maamoon Saleh, Matthew Kirkham, Sana Khajehpour, Ali Aghazadeh‐Habashi, Jared James Barrott · 2021 · Biomedicines
  97. Lipocalin-2 Inhibits Osteosarcoma Cell Metastasis by Suppressing MET Expression via the MEK–ERK Pathway
    Ko‐Hsiu Lu, Jia‐Sin Yang, Yi‐Hsien Hsieh, Hsiao-Ju Chu, Chia‐Hsuan Chou, Eric Wun-Hao Lu, Chiao‐Wen Lin, Shun‐Fa Yang · 2021 · Cancers
  98. Chemotherapy in the management of periosteal osteosarcoma: A narrative review
    Tarek Assi, Joseph Gergi Kattan, Hussein Nassereddine, Elie Rassy, Sylvain Briand, Charles Court, Benjamin Verret, Axel Le Cesne, Olivier Mir · 2021 · Journal of bone oncology
  99. Imaging of pediatric bone tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper
    Kevin Cederberg, Ramesh S. Iyer, Apeksha Chaturvedi, M. Beth McCarville, Janice D. McDaniel, Jesse K. Sandberg, Amer Shammas, Susan E. Sharp, Helen Ruth Nadel · 2022 · Pediatric Blood & Cancer
  100. Analysis of proliferation and apoptotic induction by 20 steroid glycosides in 143B osteosarcoma cells in vitro
    Catharina I. Delebinski, S. Georgi, Susann Kleinsimon, Monika Twardziok, B. Kopp, Matthias F. Melzig, Georg Seifert · 2015 · Cell Proliferation